Evoq Remedies Ltd operates in Trading & Distributors within the Industrials sector.
993 historical price candles were omitted because the exchange source has not been verified.
No positive flags triggered.
₹ crore, by fiscal year
% of revenue, by fiscal year
Comparable companies from the narrowest available industry classification.
Reported profit and loss, balance sheet, cash flow and growth history.
Annual operating, return, leverage and working-capital ratios.
Current futures and options contracts with compact option-chain pages.
Mutual-fund schemes that disclosed a holding in the company.
Annual reports, exchange filings, offer documents, ratings and earnings-call material.
Upcoming dates and the company’s corporate-action history.
Latest exchange announcements, filings and downloadable documents.
Standalone figures
| Ratio | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|
| Margins | |||
| Gross margin % | 61.5% | -11.3% | 0.1% |
| EBITDA margin % | -40.5% | -19% | -5.7% |
| EBIT margin % | -40.7% | -19.4% | -5.9% |
| PAT margin % | 11.1% | 0.3% | -0.9% |
| Working capital | |||
| Receivable days | — | — | — |
| Inventory days | 732 | 62 | 24 |
| Payable days | — | — | — |
| NWC days | — | — | — |
| Leverage | |||
| Current ratio | 3.17 | 9.1 | 6.78 |
| Debt to EBITDA | — | — | — |
| Debt to equity | — | — | — |
| Interest coverage | — | — | — |
| Asset turnover | 0.11 | 0.24 | 0.49 |
| Return ratios | |||
| Return on assets % | 1.2% | 0.1% | -0.5% |
| Return on capital employed % | 2.4% | 0.4% | -0.6% |
| Return on equity % | — | — | — |
Derived from reported annual statements. ROCE uses EBIT over capital employed (total assets less current liabilities). Day counts average the opening and closing balance; receivables turn on revenue, inventory and payables on cost of goods sold.
| Holder (%) | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|
| 11.21% | 11.21% | 11.21% | 0.02% | |
| FII | 0% | 0% | 0% | 0% |
| DII | 0% | 0% | 0% | 0% |
| Government | 0% | 0% | 0% | 0% |
| 88.79% | 88.79% | 88.79% | 99.98% | |
| No. of shareholders | 1,577 | 1,723 | 1,679 | 1,655 |
Promoter holding down 11.19 percentage points since Sep 2024.
Current officeholders as filed with BSE. A person holding two offices is listed once per office.
Only about 210 stocks have listed futures and options. Contracts appear here for those, refreshed after each close.
No scheme among the 32 fund houses on record reported a position in Evoq Remedies Ltd. Portfolios are published monthly by each AMC; coverage is still partial.
Corporate actions, results dates and filings will appear here once ingested.
Documents link to external sources (exchange filings, company investor pages).
Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Approval Of Extension Of Time For Holding 16Th Annual General Meeting ('AGM') For The Financial Year Ended 31St March 2026
Closure of Trading Window
| Date | Category | Subject | Filing |
|---|---|---|---|
| 1 Oct 2026, 6:34 pm | Company Update General | Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Approval Of Extension Of Time For Holding 16Th Annual General Meeting ('AGM') For The Financial Year Ended 31St March 2026 | |
| 30 Sept 2026, 5:16 pm | Insider Trading / SAST Closure of Trading Window |
Closure of Trading Window |
| ₹ Cr | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|
| 4 | 12 | 26 | |
| COGS | 2 | 13 | 25 |
| Gross profit | 2 | -1 | 0 |
| 4 | 1 | 1 | |
| Operating profit (EBITDA) | -2 | -2 | -1 |
| OPM % | -40.5% | -19% | -5.7% |
| Depreciation | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 |
| 2 | 2 | 1 | |
| Profit before tax | 1 | 0 | -0 |
| Tax | 0 | 0 | -0 |
| Tax % | 26.2% | 69.2% | -4% |
| 0 | 0 | -0 | |
| PAT margin % | 11.1% | 0.3% | -0.9% |
| EPS (₹) | 1.3 | 0 | -0.1 |
| Annual report | Annual report for Mar 2024 | Annual report for Mar 2025 | — |
| ₹ Cr | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|
| Equity capital | — | — | — |
| Reserves | — | — | — |
| Borrowings | — | — | — |
| 37 | 50 | 52 | |
| Total equity & liabilities | 37 | 50 | 52 |
| Fixed assets | — | 0 | 0 |
| CWIP | — | — | — |
| Investments | 0 | 0 | 0 |
| 37 | 50 | 52 | |
| Total assets | 37 | 50 | 52 |
| ₹ Cr | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|
| 5 | -15 | -0 | |
| -0 | -0 | 0 | |
| -5 | 15 | 0 | |
| Net cash flow | -0 | 0 | -0 |
| Free cash flow | 5 | -15 | -0 |
| CFO / Operating profit % | — | — | — |
| Company | Mkt Cap | EV | Revenue | EBITDA | OPM | PAT | NPM | ROCE | ROE | WC Days |
|---|---|---|---|---|---|---|---|---|---|---|
| Redington LimitedREDINGTONREDINGTON | ₹31,112 Cr | ₹33,749 Cr | ₹1,28,133 Cr | ₹2,537 Cr | 1.9% | ₹1,701 Cr | 1.1% | 21.7% | 15.8% | 34 |
| Mmtc LimitedMMTCMMTC | ₹8,444 Cr | ₹8,444 Cr | ₹3 Cr | ₹-179 Cr | — | ₹447 Cr | — | -0.5% | 20.3% | -2,38,864 |
| Mstc LimitedMSTCLTDMSTCLTD | ₹4,969 Cr | ₹5,114 Cr | ₹386 Cr | ₹236 Cr | 60.6% | ₹234 Cr | 59.1% | 34.9% | 26.6% | -92 |
| Bn Agrochem LimitedBNAGROCHEMBNAGROCHEM | ₹2,228 Cr | ₹2,310 Cr | ₹299 Cr | ₹-37 Cr | -12.5% | ₹20 Cr | 6.6% | 12% | 8.5% | 130 |
| Creative Newtech LimitedCNLCNL | ₹1,619 Cr | ₹1,943 Cr | ₹2,783 Cr | ₹99 Cr | 3.2% | ₹74 Cr | 2.6% | 29.2% | 21.4% | 75 |
| Pervasive Commodities LtdPERVASIVEPERVASIVE | ₹1,090 Cr | ₹1,090 Cr | ₹43 Cr | ₹-0 Cr | -1.1% | ₹-0 Cr | -0.1% | 0% | -0.1% | 548 |
| RRP Defense LtdRRPDEFENSERRPDEFENSE | ₹842 Cr | ₹844 Cr | ₹12 Cr | ₹-1 Cr | -8.4% | ₹-1 Cr | -8.2% | -13.7% | -13.7% | -15 |
| The Yamuna Syndicate LtdYSLYSL | ₹779 Cr | ₹779 Cr | ₹69 Cr | ₹2 Cr | 2.2% | ₹52 Cr | 75.3% | 0.3% | 4% | 60 |
| The State Trading Corporation Of India LimitedSTCINDIASTCINDIA | ₹636 Cr | ₹1,811 Cr | ₹0 Cr | ₹-46 Cr | — | ₹21 Cr | — | — | — | — |
| SMT Engineering LtdSMTELSMTEL | ₹598 Cr | ₹679 Cr | ₹162 Cr | ₹41 Cr | 25% | ₹23 Cr | 14.2% | 33.2% | 25.2% | 395 |
| Bijoy Hans LtdARVAYAARVAYA | ₹576 Cr | ₹579 Cr | ₹0 Cr | ₹-1 Cr | — | ₹0 Cr | — | -3.9% | -3.9% | — |
| Riddhi Siddhi Gluco Biols LtdRIDDHIRIDDHI | ₹505 Cr | ₹787 Cr | ₹236 Cr | ₹-12 Cr | -5.2% | ₹61 Cr | -5.2% | 2.8% | -0.8% | 65 |